Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 24380766)

1.

Transforming growth factor-β (TGF-β) pathway abnormalities in tenascin-X deficiency associated with CAH-X syndrome.

Morissette R, Merke DP, McDonnell NB.

Eur J Med Genet. 2014 Feb;57(2-3):95-102. doi: 10.1016/j.ejmg.2013.12.004. Epub 2013 Dec 28.

2.

Tenascin-X haploinsufficiency associated with Ehlers-Danlos syndrome in patients with congenital adrenal hyperplasia.

Merke DP, Chen W, Morissette R, Xu Z, Van Ryzin C, Sachdev V, Hannoush H, Shanbhag SM, Acevedo AT, Nishitani M, Arai AE, McDonnell NB.

J Clin Endocrinol Metab. 2013 Feb;98(2):E379-87. doi: 10.1210/jc.2012-3148. Epub 2013 Jan 2.

3.

Transforming growth factor-β and inflammation in vascular (type IV) Ehlers-Danlos syndrome.

Morissette R, Schoenhoff F, Xu Z, Shilane DA, Griswold BF, Chen W, Yang J, Zhu J, Fert-Bober J, Sloper L, Lehman J, Commins N, Van Eyk JE, McDonnell NB.

Circ Cardiovasc Genet. 2014 Feb;7(1):80-8. doi: 10.1161/CIRCGENETICS.113.000280. Epub 2014 Jan 6.

4.

A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency.

Schalkwijk J, Zweers MC, Steijlen PM, Dean WB, Taylor G, van Vlijmen IM, van Haren B, Miller WL, Bristow J.

N Engl J Med. 2001 Oct 18;345(16):1167-75.

5.

Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition.

Mao JR, Taylor G, Dean WB, Wagner DR, Afzal V, Lotz JC, Rubin EM, Bristow J.

Nat Genet. 2002 Apr;30(4):421-5. Epub 2002 Mar 4.

PMID:
11925569
6.

Tenascin-X deficiency is associated with Ehlers-Danlos syndrome.

Burch GH, Gong Y, Liu W, Dettman RW, Curry CJ, Smith L, Miller WL, Bristow J.

Nat Genet. 1997 Sep;17(1):104-8.

PMID:
9288108
7.

Broadening the spectrum of Ehlers Danlos syndrome in patients with congenital adrenal hyperplasia.

Morissette R, Chen W, Perritt AF, Dreiling JL, Arai AE, Sachdev V, Hannoush H, Mallappa A, Xu Z, McDonnell NB, Quezado M, Merke DP.

J Clin Endocrinol Metab. 2015 Jun 15:jc20152232. [Epub ahead of print]

PMID:
26075496
8.

Transplantation of reconstructed human skin on nude mice: a model system to study expression of human tenascin-X and elastic fiber components.

Zweers MC, Schalkwijk J, van Kuppevelt TH, van Vlijmen-Willems IM, Bergers M, Lethias C, Lamme EN.

Cell Tissue Res. 2005 Feb;319(2):279-87. Epub 2004 Nov 19.

PMID:
15558324
9.

Bone formation zones in heterotopic ossifications: histologic findings and increased expression of bone morphogenetic protein 2 and transforming growth factors beta2 and beta3.

Toom A, Arend A, Gunnarsson D, Ulfsparre R, Suutre S, Haviko T, Selstam G.

Calcif Tissue Int. 2007 Apr;80(4):259-67. Epub 2007 Apr 1.

PMID:
17401695
10.

Tenascin-X deficiency and Ehlers-Danlos syndrome: a case report and review of the literature.

O'Connell M, Burrows NP, van Vlijmen-Willems MJ, Clark SM, Schalkwijk J.

Br J Dermatol. 2010 Dec;163(6):1340-5. doi: 10.1111/j.1365-2133.2010.09949.x. Review.

PMID:
20649799
11.

Retinoic acid, GABA-ergic, and TGF-beta signaling systems are involved in human cleft palate fibroblast phenotype.

Baroni T, Bellucci C, Lilli C, Pezzetti F, Carinci F, Becchetti E, Carinci P, Stabellini G, Calvitti M, Lumare E, Bodo M.

Mol Med. 2006 Sep-Oct;12(9-10):237-45.

12.
14.

Well-defined clinical presentation of Ehlers-Danlos syndrome in patients with tenascin-X deficiency: a report of four cases.

Hendriks AG, Voermans NC, Schalkwijk J, Hamel BC, van Rossum MM.

Clin Dysmorphol. 2012 Jan;21(1):15-8. doi: 10.1097/MCD.0b013e32834c4bb7.

PMID:
21959861
15.

Cross-talk between interleukin-6 and transforming growth factor-beta3 regulates extracellular matrix production by human fibroblasts from subjects with non-syndromic cleft lip and palate.

Baroni T, Carinci P, Bellucci C, Lilli C, Becchetti E, Carinci F, Stabellini G, Pezzetti F, Caramelli E, Tognon M, Bodo M.

J Periodontol. 2003 Oct;74(10):1447-53.

PMID:
14653390
16.

Tenascin-X, collagen, and Ehlers-Danlos syndrome: tenascin-X gene defects can protect against adverse cardiovascular events.

Petersen JW, Douglas JY.

Med Hypotheses. 2013 Sep;81(3):443-7. doi: 10.1016/j.mehy.2013.06.005. Epub 2013 Jul 3.

17.

Hypoxia modulates the effects of transforming growth factor-beta isoforms on matrix-formation by primary human lung fibroblasts.

Papakonstantinou E, Aletras AJ, Roth M, Tamm M, Karakiulakis G.

Cytokine. 2003 Oct;24(1-2):25-35.

PMID:
14561488
18.

Vasohibin-1 expression is regulated by transforming growth factor-β/bone morphogenic protein signaling pathway between tumor-associated macrophages and pancreatic cancer cells.

Shen Z, Seppänen H, Kauttu T, Vainionpää S, Ye Y, Wang S, Mustonen H, Puolakkainen P.

J Interferon Cytokine Res. 2013 Aug;33(8):428-33. doi: 10.1089/jir.2012.0046. Epub 2013 May 7.

19.

Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis.

d'Amaro R, Scheidegger R, Blumer S, Pazera P, Katsaros C, Graf D, Chiquet M.

Front Physiol. 2012 Sep 24;3:377. doi: 10.3389/fphys.2012.00377. eCollection 2012.

20.

Tenascin-X deficiency in autosomal recessive Ehlers-Danlos syndrome.

Lindor NM, Bristow J.

Am J Med Genet A. 2005 May 15;135(1):75-80.

PMID:
15793839
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk